Assure Holdings Maintains Position in Nasdaq Capital Market Following Panel Decision

DENVER, May 16, 2024 (GLOBE NEWSWIRE) – Assure Holdings Corp. ("Assure" or the "Company") IONM, a prominent provider of intraoperative neuromonitoring (IONM) services and remote neurology services, has shared positive news with its stakeholders. The firm has officially announced receipt of a definitive written notification confirming its continued listing on the Nasdaq Capital Market. This development comes as a result of a favorable determination made by the Nasdaq Listing Qualifications Panel, maintaining the faith of investors in the Company’s fiscal health and compliance with market regulations.

Understanding the Significance for Assure Holdings

The continuity of Assure’s listing on such a prestigious platform is a testament to the Company’s adherence to stringent listing requirements and its dedication to transparent corporate governance. It instills a renewed sense of confidence among shareholders and potential investors regarding the Company’s stability and growth prospects within the competitive healthcare sector. Moreover, the Nasdaq Capital Market provides Assure with access to a broad audience of institutional and retail investors, which is invaluable for a Company seeking to expand and secure additional capital for its projects and services.

Future Outlook for Assure Holdings

Following this announcement, Assure is likely to focus on leveraging this affirmation to bolster its market position. As it continues offering cutting-edge IONM and remote neurology services, the Company is poised to scale its operations and innovate within the neuromonitoring space. Enhancing shareholder value remains a core goal, with the Nasdaq listing contributing greatly to Assure's visibility and credibility in the financial markets. The commitment to meeting Nasdaq's regulatory criteria also demonstrates Assure’s resilience and potential as a sound investment opportunity in the healthcare industry.

Assure, Nasdaq, Investment